'Pharma bro' Martin Shkreli's notoriety slows New York jury selection

NEW YORK (Reuters) - Jury selection in the New York trial of former drug company executive Martin Shkreli will enter its third day Wednesday, after some potential jurors said they could not be fair to a man who gained notoriety by raising the price of a life-saving drug more than 5,000 percent.

'Pharma bro' Martin Shkreli's notoriety slows New York jury selection
Read More


Bagikan Berita Ini